{
    "2021-06-16": [
        [
            {
                "time": "2023-10-01",
                "original_text": "智飞生物：全球首个结核疫苗获批上市，将对业绩产生积极影响",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "结核疫苗",
                        "获批上市",
                        "业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "晚间公告热点追踪：药明康德股东遭立案调查 三个交易日市值蒸发逾400亿",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股东",
                        "立案调查",
                        "市值蒸发"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "时间": "2023-10-01",
                "original_text": "万联证券：智飞生物（300122.SZ）预防性微卡获批，自研能力进一步凸显，维持“买入”评级",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "预防性微卡",
                        "自研能力",
                        "买入评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "东兴证券：智飞生物（300122.SZ）母牛分枝杆菌疫苗获批，给予“推荐”评级",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "母牛分枝杆菌疫苗",
                        "推荐评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "医药行业周报：把握新经济下的消费升级新趋势 关注二季度有望超预期的细分赛道",
                "features": {
                    "keywords": [
                        "医药行业",
                        "消费升级",
                        "细分赛道",
                        "二季度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "医药行业周报：安徽省骨科耗材带量采购启动 坚守医药创新逻辑主线",
                "features": {
                    "keywords": [
                        "医药行业",
                        "骨科耗材",
                        "带量采购",
                        "医药创新"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}